Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (331-340 of 607) with videos related to

Pageof 61
Sort By:
The European Respiratory Journal|March 23, 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosisJ Gerry Coghlan, Matthias Wolf, Oliver Distler, et al.
The Lancet. Rheumatology|July 27, 2022
Systemic sclerosis in the time of COVID-19Anna-Maria Hoffmann-Vold, Oliver Distler, Cosimo Bruni, et al.
Arthritis and Rheumatism|January 1, 2009
Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblastsXu Shi-wen, Sunil K Parapuram, Daphne Pala, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
ReplyRobyn T Domsic, Mary Lucas, Svetlana I Nihtyanova, et al.
Fibrogenesis & Tissue Repair|April 2, 2011
Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanismYunliang Chen, Andrew Leask, David J Abraham, et al.
The European Respiratory Journal|January 28, 2012
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapyGregory J Keir, Toby M Maher, David M Hansell, et al.
Fibrogenesis & Tissue Repair|March 17, 2015
Erratum to: Thrombospondin 1 is a key mediator of transforming growth factor b-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanismYunliang Chen, Andrew Leask, David J Abraham, et al.
Rheumatology (Oxford, England)|September 9, 2025
Impact of hand function impairment on daily life of patients with systemic sclerosis: a qualitative studyMark Greveling, Stefano Rodolfi, Nora El Bardai, et al.
Vascular Pharmacology|July 13, 2023
Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertensionJeries Abu-Hanna, Evangelos Anastasakis, Jigisha A Patel, et al.
The Journal of Investigative Dermatology|March 7, 2001
Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1X Shi-Wen, C P Denton, M R Dashwood, et al.
Pageof 61

Showing results (331-340 of 607) with videos related to

Sort By:
Pageof 61
The European Respiratory Journal|March 23, 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosisJ Gerry Coghlan, Matthias Wolf, Oliver Distler, et al.
The Lancet. Rheumatology|July 27, 2022
Systemic sclerosis in the time of COVID-19Anna-Maria Hoffmann-Vold, Oliver Distler, Cosimo Bruni, et al.
Arthritis and Rheumatism|January 1, 2009
Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblastsXu Shi-wen, Sunil K Parapuram, Daphne Pala, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
ReplyRobyn T Domsic, Mary Lucas, Svetlana I Nihtyanova, et al.
Fibrogenesis & Tissue Repair|April 2, 2011
Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanismYunliang Chen, Andrew Leask, David J Abraham, et al.
The European Respiratory Journal|January 28, 2012
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapyGregory J Keir, Toby M Maher, David M Hansell, et al.
Fibrogenesis & Tissue Repair|March 17, 2015
Erratum to: Thrombospondin 1 is a key mediator of transforming growth factor b-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanismYunliang Chen, Andrew Leask, David J Abraham, et al.
Rheumatology (Oxford, England)|September 9, 2025
Impact of hand function impairment on daily life of patients with systemic sclerosis: a qualitative studyMark Greveling, Stefano Rodolfi, Nora El Bardai, et al.
Vascular Pharmacology|July 13, 2023
Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertensionJeries Abu-Hanna, Evangelos Anastasakis, Jigisha A Patel, et al.
The Journal of Investigative Dermatology|March 7, 2001
Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1X Shi-Wen, C P Denton, M R Dashwood, et al.
Pageof 61